Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

被引:0
|
作者
Taylor M. Patek
Chengwen Teng
Kaitlin E. Kennedy
Carlos A. Alvarez
Christopher R. Frei
机构
[1] The University of Texas at Austin,Pharmacotherapy Division, College of Pharmacy
[2] The University of Texas Health Science Center at San Antonio,Pharmacotherapy Education and Research Center, Long School of Medicine
[3] Texas Tech University Health Sciences Center,Division of Clinical/Translational Research, Hodge School of Pharmacy
[4] South Texas Veterans Health Care System,undefined
[5] University Health System,undefined
来源
Drug Safety | 2020年 / 43卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:17 / 22
页数:5
相关论文
共 50 条
  • [1] Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Patek, Taylor M.
    Teng, Chengwen
    Kennedy, Kaitlin E.
    Alvarez, Carlos A.
    Frei, Christopher R.
    [J]. DRUG SAFETY, 2020, 43 (01) : 17 - 22
  • [2] Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Taylor M. Patek
    Chengwen Teng
    Kaitlin E. Kennedy
    Carlos A. Alvarez
    Christopher R. Frei
    [J]. Drug Safety, 2020, 43 : 825 - 825
  • [3] Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) (vol 43, pg 17, 2020)
    Patek, Taylor M.
    Teng, Chengwen
    Kennedy, Kaitlin E.
    Alvarez, Carlos A.
    Frei, Christopher R.
    [J]. DRUG SAFETY, 2020, 43 (08) : 825 - 825
  • [4] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Chengwen Teng
    Christopher R. Frei
    [J]. Drugs - Real World Outcomes, 2022, 9 : 23 - 29
  • [5] Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Baus, Courtney
    Wilson, James P.
    Frei, Christopher R.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (11): : 1504 - 1509
  • [6] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Frei, Christopher R.
    [J]. DRUGS-REAL WORLD OUTCOMES, 2022, 9 (01) : 23 - 29
  • [7] Pharmacovigilance Analysis Of FDA Adverse Event Reporting System (FAERS) Events For Inclisiran
    Rajak, Kripa
    Halder, Anupam
    Gautam, Seema Sharma
    Khanal, Resha
    Atrash, Anas
    Goswami, Rohan
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [8] Compartment syndrome associations with drugs: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)
    Kong, Wenqiang
    Shu, Yunfeng
    Tang, Juan
    Wan, Jie
    Yang, Xueting
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
  • [9] A REALWORLD PHARMACOVIGILANCE STUDY OF FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) EVENTS FOR EMPAGLIFLOZIN AND DAPAGLIFLOZIN
    Milutinovic, Stefan
    Petrovic, Marija
    Jancic, Predrag
    Trajkovic, Hristina
    Alarcon, Ricardo Orlando Escarcega
    Chazal, Richard A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 319 - 319
  • [10] A Real-World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) for Mavacamten
    Yukselen, Zeynep
    Raju, Arvind Kumar Venkataramana
    Kumar, Pramukh Arun
    Ujjawal, Aditi
    Dasari, Mahati
    Parajuli, Shreyash
    Nakhla, Michael
    Bansal, Kannu
    Ganatra, Sarju
    Dani, Sourbha S.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024,